Become Express Subscriber
Advertisement

Serum Institue of India’s Poonawalla expects Omicron-specific vaccine in 6 months: Report

SII, the world's biggest vaccine maker, produces AstraZeneca's COVID-19 vaccine under the brand name Covishield.

Serum Institute of India's Chief Executive Officer Adar Poonawalla (File Photo)

Serum Institute of India’s (SII) Chief Executive Officer Adar Poonawalla said he expects an Omicron-specific vaccine in the country in six months, NDTV reported on Monday.

SII, the world’s biggest vaccine maker, produces AstraZeneca’s COVID-19 vaccine under the brand name Covishield.

SII did not immediately respond to a Reuters request for comment.

Subscriber Only Stories
Premium
Premium
Premium
Premium
First published on: 15-08-2022 at 11:14:51 pm
Next Story

2 men on bike shoot dead property dealer in Delhi’s Jamia Nagar

Home
ePaper
Next Story
X